EQ/T.Rowe Price Health Sciences Portfolio's EQ/T.Rowe Price Health Sciences Portfolio has disclosed 187 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-03-31. The current portfolio value is calculated to be $189.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 11%.
EQ/T.Rowe Price Health Sciences Portfolio's
Total Assets is $194.68 Mil , Total Liabilities is $4.47 Mil , Net Assets is $190.20 Mil.
In EQ/T.Rowe Price Health Sciences Portfolio's current portfolio as of 2024-03-31, the top 5 holdings are
Eli Lilly and Co (LLY), UnitedHealth Group Inc (UNH), Intuitive Surgical Inc (ISRG), Merck & Co Inc (MRK) and Thermo Fisher Scientific Inc (TMO),
not including call and put options.
EQ/T.Rowe Price Health Sciences Portfolio did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for EQ/T.Rowe Price Health Sciences Portfolio, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for EQ/T.Rowe Price Health Sciences Portfolio, which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for EQ/T.Rowe Price Health Sciences Portfolio.